Press and Reviews
What people are saying about the book, Commercializing Successful Biomedical Technologies
Nature Biotechnology calls it "The Bioentrepreneur's Road Map" that "... develops a seven-stage framework and... does an excellent job of identifying and organizing the major issues"
Nature Biotechnology Book Review by Michael Bielski
IEEE EMBS Magazine book review: Recommends this "well-written introduction to the field of drug and device development and commercialization" as a text for business schools, biomedical engineering design courses, and as a "first read for faculty" involved in drug and device research.
IEEE Engineering in Medicine and Biology Magazine, review by Paul King, Vanderbilt University
This book is packed with useful details on all aspects of launching a new biomedical company. I highly recommend it to anyone contemplating a new venture.
Hanson Gifford, serial entrepreneur and co-founder of The Foundry
Dr. Mehta’s book is a comprehensive and practical overview of all the steps and challenges to successfully develop and commercialize a product from idea to income. His points are illustrated with real life examples throughout. Students and professionals alike should read this book!
Jim Mullen, CEO of Biogen-Idec and past President of the Biotechnology Industry Organization
The book covers all the things that matter but are never written down in a comprehensive text.
Carmichael Roberts, General partner at Northbridge Partners,
Vice Chairman, WMR Biomedical and cofounder of Surface Logix
This text covers the commercialization of life science technologies in the areas of pharmaceuticals, biotechnologies, medical devices, and diagnostics, and spanning the development process from invention through marketing and sales. Shreefal Mehta writes clearly and with a practical bent, using case examples and drawing on his own substantial industry experience to help chart a path through the complex landscape of new product development.
Paul Yock, Director of the Stanford Program in Biodesign and
Professor at Stanford Graduate School of Business and School of Medicine
Shreefal Mehta's book provides insights and important information about the major steps entrepreneurs must take as an idea progresses through the various steps of commercialization. This text is a must for anyone developing a new medical product.
Joseph Bronzino, Editor-in-Chief of The Biomedical Engineering Handbook (CRC Press, 3rd Edition, 2006), and
recipient of the IEEE Millennium Medal for “his contributions to biomedical engineering research and education”
Dr Mehta’s book is on my table as a handy reference and overview of the business and product development challenges involved in the health care industry.
Christoph Hergersberg, Global Technology Leader, Biosciences, General Electric Global Research Center
Venture philanthropists, venture capitalists, state organizations, and angel investors involved in building new life sciences-based ventures can use this book to inform their investment decision making process. Dr Mehta’s comprehensive book helps funding organizations and entrepreneurs identify the companies and technologies most likely to succeed.
Lesa Mitchell, Vice President, Advancing Innovation, the Ewing Marion Kauffman Foundation
Dr Mehta’s book is an excellent guide on how to overcome obstacles in commercializing innovative medical technologies. It covers market research, intellectual property rights, business models, and regulatory affairs. Of note are the real life examples, the extensive discussion of Intellectual Property Rights in relation to business models, and that of interaction with the FDA for innovative projects.
Dr. Henk van Houten, Senior Vice President Philips Research, Program Manager Healthcare
The 'How-To Bible' for launching a product - If I had to recommend one great book to get you started on the road to launching a product, then begin with "Commercializing Successful Biomedical Technologies."
Joe Sasenick, Washington Biotechnology & Biomedical Association
Shreefal Mehta's book highlights the right questions to ask in order to truly understand the impact of reimbursement and health economics, too often ignored in product development, on new devices, drugs, and biologicals.
Parashar Patel, Vice President, Health Economics & Reimbursement, Boston Scientific
This book is a must for starters in the industry and for people who have collected different pieces of the puzzle through scattered sources and need to organize it in their minds to put it in perspective.
Atul Gupta, MIT Sloan school MBA candidate and Kauffman Foundation intern
